Seven retractions, a resignation, and lawsuit settlements haven’t stopped Anil Potti from publishing
“Neither snow nor rain nor heat nor gloom of night” keeps U.S. mail carriers from delivering your letters and packages, and neither seven retractions, nor being forced to resign, nor malpractice settlements (and an ongoing case) keeps former Duke oncologist Anil Potti from publishing papers.
Potti’s latest effort, “A Pathway-Based Approach to Identify Molecular Biomarkers in Cancer,” appeared last month in the Annals of Surgical Oncology. The subject of the review is the same as many of his now-retracted papers, none of which are cited by the new paper.
The paper took a while to get through peer review and editing. It was first submitted in May 2010, two months before The Cancer Letter reported that Potti had lied on a grant application about being a Rhodes Scholar and his research program really started to unravel.
We asked Potti’s co-author, Marvaretta Stevenson, about the delay, and whether she had any trepidation about publishing a paper with her former Duke colleague. She had published several papers with Potti before things fell apart, none of which have been retracted, and presumably, she could have withdrawn this paper at some point. We asked similar questions of the editor of the journal, and will update with anything we hear back from either of them.
In case you were thinking that the Annals of Surgical Oncology was some backwater journal where pretty much anyone can publish, here’s a “Special Announcement” on the journal’s homepage:
ASO IMPACT FACTOR RISES
The 2010 Impact Factor for Annals of Surgical Oncology has risen to 4.182, the third consecutive annual increase in the journal’s impact ranking. The journal is now ranked 8 of 187 journals publishing in Thomson Reuters’ (formerly ISI) subject category “Surgery,” making it the top ranked oncology journal in surgery
In short, it ain’t no slouch.